Given the high prevalence of ILD among Asian IIM patients who are positive for the anti-SAE1 autoantibody, it remains to be determined whether ILD screening is necessary for patients positive for the anti-SAE1 autoantibody, with or without IIM, especially within the Asian population. Here, SAE1 is linked to acquired idiopathic inflammatory myopathy.